AG
TECX

Algert Global’s Tectonic Therapeutic TECX Stock Holding History

Algert Global’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,600
Closed -$73K – 1413
2022
Q1 		$73K Buy
4,600
+3,761
+448% +$77.7K ﹤0.01% 1126
2021
Q4 		$39K Buy
+839
New +$48.2K ﹤0.01% 942

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Algert Global's TECX Position: Q2 2022 in Review

Algert Global sold out of Tectonic Therapeutic (TECX) in Q2 2022, closing a stake of 4,600 shares — an estimated $73K sold.

Algert Global first reported a position in TECX in Q4 2021 and held it in 2 quarters. The position peaked at $73K in Q1 2022. 64 funds tracked by Wall St. Rank hold TECX as of Q2 2022.

  • Algert Global reported no remaining Tectonic Therapeutic position as of Q2 2022 after selling out during the quarter.
  • Algert Global sold 4,600 Tectonic Therapeutic shares in Q2 2022, an estimated $73K.
  • Algert Global first reported a position in Tectonic Therapeutic in Q4 2021 and held it in 2 quarters.
  • Algert Global's Tectonic Therapeutic position peaked at $73K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.